High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.

[1]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[2]  J. Seoane.  Escaping from the TGFβ anti-proliferative control , 2006 .

[3]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[4]  C. Arteaga.  Inhibition of TGFβ signaling in cancer therapy , 2006 .

[5]  Luyang Sun,et al.  Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis , 2005, Nature.

[6]  Ryan M. O’Connell,et al.  TLR agonists regulate PDGF‐B production and cell proliferation through TGF‐β/type I IFN crosstalk , 2005, The EMBO journal.

[7]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[8]  Wei He,et al.  Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Mitchel S Berger,et al.  Neural stem cells and the origin of gliomas. , 2005, The New England journal of medicine.

[10]  C. Heldin,et al.  Non-Smad TGF-β signals , 2005, Journal of Cell Science.

[11]  Jonathan M. Yingling,et al.  Development of TGF-β signalling inhibitors for cancer therapy , 2004, Nature Reviews Drug Discovery.

[12]  A. Östman.  PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma , 2004 .

[13]  U. Eriksson,et al.  The PDGF family: four gene products form five dimeric isoforms. , 2004, Cytokine & growth factor reviews.

[14]  S. Anderson,et al.  Integration of Smad and Forkhead Pathways in the Control of Neuroepithelial and Glioblastoma Cell Proliferation , 2004, Cell.

[15]  You-Ming Li,et al.  Expression of platelet-derived growth factor-BB in liver tissues of patients with chronic hepatitis B. , 2004, World journal of gastroenterology.

[16]  R. Maciunas,et al.  Transforming growth factor b as a potential tumor progression factor among hyperdiploid glioblastoma cultures: Evidence for the role of platelet-derived growth factor , 1997, Journal of Neuro-Oncology.

[17]  B. Druker,et al.  Imatinib as a paradigm of targeted therapies. , 2004, Advances in cancer research.

[18]  J. Massagué,et al.  Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer , 2003, Nature Reviews Cancer.

[19]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[20]  Carlos L. Arteaga,et al.  Targeting the TGFβ signaling network in human neoplasia , 2003 .

[21]  W. Cavenee,et al.  Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. , 2003, The American journal of pathology.

[22]  J. Massagué,et al.  A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. , 2003, Molecular cell.

[23]  J. Rich.  The role of transforming growth factor-beta in primary brain tumors. , 2003, Frontiers in bioscience : a journal and virtual library.

[24]  L. Parada,et al.  The Molecular and Genetic Basis of Neurological Tumours , 2002, Nature Reviews Cancer.

[25]  M. Lamfers,et al.  Efficient and Selective Gene Transfer into Primary Human Brain Tumors by Using Single-Chain Antibody-Targeted Adenoviral Vectors with Native Tropism Abolished , 2002, Journal of Virology.

[26]  G. Reifenberger,et al.  The WHO Classification of Tumors of the Nervous System , 2002, Journal of neuropathology and experimental neurology.

[27]  Allan Balmain,et al.  TGF-β signaling in tumor suppression and cancer progression , 2001, Nature Genetics.

[28]  D. Louis,et al.  PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. , 2001, Genes & development.

[29]  R. DePinho,et al.  Malignant glioma: genetics and biology of a grave matter. , 2001, Genes & development.

[30]  Eric C. Holland,et al.  Gliomagenesis: genetic alterations and mouse models , 2001, Nature Reviews Genetics.

[31]  L. Khachigian,et al.  Induction of Platelet-derived Growth Factor B-chain Expression by Transforming Growth Factor-β Involves Transactivation by Smads* , 2000, The Journal of Biological Chemistry.

[32]  R. Puri,et al.  Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas. , 2000, Cancer research.

[33]  D. Bigner,et al.  Transforming Growth Factor-β-mediated p15INK4BInduction and Growth Inhibition in Astrocytes Is SMAD3-dependent and a Pathway Prominently Altered in Human Glioma Cell Lines* , 1999, The Journal of Biological Chemistry.

[34]  S. Toda,et al.  Immunohistochemical expression of growth factors in subacute thyroiditis and their effects on thyroid folliculogenesis and angiogenesis in collagen gel matrix culture , 1999, The Journal of pathology.

[35]  C. Heldin,et al.  Expression of transforming‐growth‐factor (TGF)‐β receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF‐β1 , 1999 .

[36]  W. E. Fahl,et al.  Identification and characterization of an essential, activating regulatory element of the human SIS/PDGFB promoter in human megakaryocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.